课题基金 / 基金详情

Development of biological response modifiers of neurotrophins and their receptors

Development of biological response modifiers of neurotrophins and their receptors
神经营养素及其受体生物反应调节剂的开发
批准号：
171953
负责人：
Saragovi Horacio U
金额：
$48.66万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2008
资助国家：
加拿大
项目状态：
已结题
起止时间：
2008-09-01 至 2012-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=171953&lang=en
关键词：
Cancer Molecular Biology Neurodegeneration Peptidomimetic Receptor Pharmacology Structural Biology

项目摘要

项目成果

Saragovi Horacio U的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Neurotrophins are a family of neuronal growth factors which bind to and activate specific receptors, which in turn stimulate the growth, survival and differentiation of neurons and other tissues. We propose to continue our studies of how neurotrophins bin
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of effective targeted anti-GD2 cancer immunotherapies, that synergize with immune-checkpoint inhibitor blockades
Innovation of Proprietary Liquid Biopsy Assays for Diagnosis of Early Stage Ovarian Cancer
Innovation of a Proprietary Liquid Biopsy Strategy for Diagnosis of Early Stage Ovarian Cancer
Elucidating the paradox of TrkC receptor isoforms causing either neuronal survival or degeneration: target validation and therapeutic rationale using isoform-selective pharmacological and biological tools.
海外基金